EGR2 Antikörper (C-Term)
Kurzübersicht für EGR2 Antikörper (C-Term) (ABIN2792631)
Target
Alle EGR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- PFACDYCGRK FARSDERKRH TKIHLRQKER KSSAPSASVP APSTASCSGG
-
Kreuzreaktivität
- Hund, Human, Maus, Schwein, Ratte (Rattus)
-
Homologie
- Cow: 100%, Dog: 92%, Horse: 85%, Human: 100%, Mouse: 100%, Pig: 92%, Rabbit: 92%, Rat: 92%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against EGR2. It was validated on Western Blot and immunohistochemistry.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human EGR2
-
-
-
-
Applikationshinweise
-
WB Suggested Anti-EGR2 Antibody Titration: 0.2-1 µg/mL
ELISA Titer: 1:312500
Positive Control: Human Lung.
Optimal working dilutions should be determined experimentally by the investigator. -
Kommentare
-
Antigen size: 476 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "Acquired initiating mutations in early hematopoietic cells of CLL patients. ..." in: Cancer discovery, Vol. 4, Issue 9, pp. 1088-101, (2014) (PubMed).
: "A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages." in: Biochimica et biophysica acta, Vol. 1833, Issue 8, pp. 1936-46, (2013) (PubMed).
: "Retinoic acid regulates myelin formation in the peripheral nervous system." in: Glia, Vol. 58, Issue 12, pp. 1451-64, (2010) (PubMed).
-
: "Acquired initiating mutations in early hematopoietic cells of CLL patients. ..." in: Cancer discovery, Vol. 4, Issue 9, pp. 1088-101, (2014) (PubMed).
-
- EGR2 (Early Growth Response 2 (EGR2))
-
Andere Bezeichnung
- EGR2
-
Hintergrund
-
The early growth response protein 2 (EGR2) is a transcription factor with three tandem C2H2-type zinc fingers. Mutations in this gene are associated with the autosomal dominant Charcot-Marie-Tooth disease, type 1.The early growth response protein 2 is a transcription factor with three tandem C2H2-type zinc fingers. Mutations in this gene are associated with the autosomal dominant Charcot-Marie-Tooth disease, type 1. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: CMT1D, CMT4E, DKFZp686J1957, FLJ14547, KROX20, AT591
Protein Interaction Partner: RPL7L1, HN1L, RIMKLB, RBM15B, NDUFS2, BPGM, SRA1, DTX1, WWP2, UBC, UBE2I, NAB2, SOX8, MED31, SOX10, HCFC1, ACP5, NFATC1, FASLG,
Protein Size: 476 -
Molekulargewicht
- 50 kDa
-
Gen-ID
- 1959
-
NCBI Accession
- NM_000399, NP_000390
-
UniProt
- P11161
Target
-